Replimune Group, Inc.

NASDAQ:REPL

11.44 (USD) • At close March 11, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Revenue 0004.0420000000000000000000000000000
Cost of Revenue 000.7360.6550.70.70.6210.5281.2891.2241.2271.1561.1551.1391.1251.1010000000000000000
Gross Profit 00-0.7363.387-0.7-0.7-0.621-0.528-1.289-1.224-1.227-1.156-1.155-1.139-1.125-1.1010000000000000000
Gross Profit Ratio 0000.8380000000000000000000000000000
Reseach & Development Expenses 48.00443.44842.97242.57942.84749.10140.43737.95430.26128.83429.47821.73619.35319.90218.55416.22514.32214.0512.15711.18811.9488.1687.4575.4137.8574.9623.9364.5033.5733.1492.2912.485
General & Administrative Expenses 00000000012.74511.398010.3459.3458.8275.9595.9535.6135.6765.1974.7164.0743.452.4132.282.1421.9432.5621.1591.1070.8851.236
Selling & Marketing Expenses 00000000000000000000000000000000
SG&A 18.01515.46814.39516.17713.69314.7315.21115.04111.36912.74511.39810.25210.3459.3458.8275.9595.9535.6135.6765.1974.7164.0743.452.4132.282.1421.9432.5621.1591.1070.8851.236
Other Expenses 000-0.5361.344-1.4091.374-1.1450.147-2.659-2.019-0.21-0.241-0.356-0.2520.334-0.454-0.517-0.028-0.026-0.1920.1110.091-0.2310.0050.0580.62-0.6170.094-0.472-0.8730
Operating Expenses 66.01958.91656.92958.08756.12563.38855.25552.11341.02341.00540.02531.06428.96528.52226.59321.36819.72518.90817.14715.49315.71311.62210.2867.2358.567.1815.4416.444.0933.622.7093.875
Operating Income -66.019-58.916-57.367-58.756-56.54-63.831-55.648-52.995-41.63-41.579-40.876-31.988-29.698-29.247-27.381-22.184-20.275-19.663-17.833-16.385-16.664-12.242-10.907-7.826-10.137-7.104-5.879-7.065-4.732-4.256-3.176-3.208
Operating Income Ratio 000-14.5360000000000000000000000000000
Total Other Income Expenses Net 0.2545.8613.5953.6165.8933.5866.2944.0441.94-1.523-1.3770.2920.024-0.1080.070.685-1.508-0.4320.340.5960.4751.1031.3991.172.4640.643-4.1650.2170.378-0.404-0.376-0.144
Income Before Tax -65.765-53.055-53.772-55.14-50.647-60.245-49.354-48.951-39.69-43.102-42.253-31.696-29.674-29.355-27.311-21.499-21.783-20.095-17.493-15.789-16.189-11.139-9.508-6.656-7.673-6.461-10.044-6.848-4.354-4.66-3.552-3.865
Income Before Tax Ratio 000-13.6420000000000000000000000000000
Income Tax Expense 0.57500-0.0650.473-0.2010.2010.7121.636-2.109-1.4670.3430.3140.2010.3060.8940.3530.3310.8170.8640.6420.3060.091-0.810.0050.0585.223-0.2090.3550.568-0.030
Net Income -66.34-53.055-53.772-55.075-51.12-60.044-49.555-49.239-39.69-43.102-42.253-31.696-29.674-29.355-27.311-21.499-21.783-20.095-17.493-15.789-16.189-11.139-9.508-6.656-7.673-6.461-10.044-6.848-4.354-4.66-3.552-3.865
Net Income Ratio 000-13.6260000000000000000000000000000
EPS -0.79-0.68-0.78-0.9-0.77-0.9-0.75-0.87-0.69-0.79-0.78-0.67-0.57-0.56-0.53-0.46-0.44-0.46-0.44-0.41-0.46-0.35-0.3-0.21-0.24-0.26-0.33-1.37-0.2-0.22-0.17-0.78
EPS Diluted -0.79-0.68-0.78-0.9-0.77-0.9-0.75-0.87-0.69-0.79-0.78-0.67-0.57-0.56-0.53-0.46-0.44-0.46-0.44-0.41-0.46-0.35-0.3-0.21-0.24-0.26-0.33-1.37-0.14-0.15-0.12-0.78
EBITDA -62.794-50.161-51.514-53.203-48.81-58.491-47.467-47.736-37.519-41.579-40.876-30.911-28.697-28.384-26.416-20.654-20.517-18.97-16.336-14.841-15.606-11.522-10.087-7.193-7.636-6.425-5.408-6.412-4.062-3.593-2.686-3.159
EBITDA Ratio 000-14.3290000000000000000000000000000